Le sujet est vraiment intéressant et ça m’aurait plu d’avoir un avis éclairé à contre-courant de la pensée majoritaire sur lemmy/reddit mais l’article ne parle pas du fond du problème, dommage.

Developing new drugs costs millions and can lasts decades, especially because of clinical trials. Without IP protection, the company making the effort to find new drugs would go bankrupt (the price of newly found drugs must also pay for other drug research that did not succeed). I don’t know how it works in the USA, in France the system is that that the IP protection lasts 10 years after releasing the drug on the market, then other companies can copy it. And during this 10 years period, the price is regulated by the government.

Do you use a linter? I switched to Ruff several months ago and it is amazing, it finds many defects and runs very quickly (even on huge disgusting legacy files)

I like this idea, I had never thought about it this way. But it would be hard to implement, what about owning things that does not physically exist? (Like a company)